RxDoctor Payments Data

Donald Feinsod, MD

Procedural Dermatology · Hewlett, NYNPI 1215009410

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $492 and has fallen 94.9% since, to $25 in 2024. That places this record below the midpoint for procedural dermatology clinicians in NY, where the typical reported total is $3,601.

$1,195in general payments, 2019–2025

Across 32 payments — averaging $37.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$237
  • Pfizer$208
  • AbbVie$171
  • Arcutis Biotherapeutics, Inc.$156
  • Bristol Myers Squibb$136
  • Amgen$123
  • plus $165 from 4 others

What the payments were for

  • Food & beverage$1,195100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC2$237
Pfizer6$208
AbbVie(2 entities)9$171
Arcutis Biotherapeutics, Inc.1$156
Bristol Myers Squibb3$136
Amgen1$123
UCB, Inc.3$59
LEO Pharma Inc.2$41
Novartis2$35
Strata Skin Sciences, Inc.3$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,195 in reported general payments places this provider in the 35th percentile of 69 procedural dermatology providers in New York.

See all procedural dermatology providers in New York

Medicare billing

Part B allowed, 2024
$129,773
Medicare patients
223
Services billed
1,775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ValacyclovirValacyclovir Hcl17$1,132
Ursodiol11$524
Mupirocin34$305

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Hewlett

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →